DK1324980T3 - Citrullimyciner, og fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents
Citrullimyciner, og fremgangsmåde til deres fremstilling og deres anvendelse som lægemidlerInfo
- Publication number
- DK1324980T3 DK1324980T3 DK01986297T DK01986297T DK1324980T3 DK 1324980 T3 DK1324980 T3 DK 1324980T3 DK 01986297 T DK01986297 T DK 01986297T DK 01986297 T DK01986297 T DK 01986297T DK 1324980 T3 DK1324980 T3 DK 1324980T3
- Authority
- DK
- Denmark
- Prior art keywords
- citrullimycins
- pharmaceuticals
- preparation
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00121566A EP1193249A1 (fr) | 2000-10-02 | 2000-10-02 | Citrullimycines, procédé pour leur préparation, et leur utilisation comme composés pharmaceutiques |
PCT/EP2001/011192 WO2002028824A1 (fr) | 2000-10-02 | 2001-09-27 | Citrullimycines, leur procede de production et leur utilisation en tant qu'agents pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1324980T3 true DK1324980T3 (da) | 2008-05-13 |
Family
ID=8169998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01986297T DK1324980T3 (da) | 2000-10-02 | 2001-09-27 | Citrullimyciner, og fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler |
Country Status (14)
Country | Link |
---|---|
US (1) | US6930130B2 (fr) |
EP (2) | EP1193249A1 (fr) |
JP (1) | JP2004510758A (fr) |
AR (1) | AR032478A1 (fr) |
AT (1) | ATE385494T1 (fr) |
AU (2) | AU2002223566B2 (fr) |
CA (1) | CA2424273A1 (fr) |
DE (1) | DE60132703T2 (fr) |
DK (1) | DK1324980T3 (fr) |
ES (1) | ES2298279T3 (fr) |
IL (1) | IL155101A0 (fr) |
MX (1) | MXPA03002343A (fr) |
PT (1) | PT1324980E (fr) |
WO (1) | WO2002028824A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040012396A (ko) * | 2002-08-03 | 2004-02-11 | 대한민국(관리부서:농촌진흥청) | 뇌신경성장인자 증강작용을 갖는 백강잠 추출물 및 이의활성성분을 함유하는 약학적 제제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252472A (en) * | 1988-03-22 | 1993-10-12 | Hoechst Aktiengesellschaft | Process for the production of furans and lactones from streptomyces |
-
2000
- 2000-10-02 EP EP00121566A patent/EP1193249A1/fr not_active Withdrawn
-
2001
- 2001-09-27 MX MXPA03002343A patent/MXPA03002343A/es active IP Right Grant
- 2001-09-27 AU AU2002223566A patent/AU2002223566B2/en not_active Ceased
- 2001-09-27 PT PT01986297T patent/PT1324980E/pt unknown
- 2001-09-27 CA CA002424273A patent/CA2424273A1/fr not_active Abandoned
- 2001-09-27 WO PCT/EP2001/011192 patent/WO2002028824A1/fr active IP Right Grant
- 2001-09-27 ES ES01986297T patent/ES2298279T3/es not_active Expired - Lifetime
- 2001-09-27 DE DE60132703T patent/DE60132703T2/de not_active Expired - Lifetime
- 2001-09-27 IL IL15510101A patent/IL155101A0/xx unknown
- 2001-09-27 DK DK01986297T patent/DK1324980T3/da active
- 2001-09-27 JP JP2002532410A patent/JP2004510758A/ja not_active Withdrawn
- 2001-09-27 EP EP01986297A patent/EP1324980B1/fr not_active Expired - Lifetime
- 2001-09-27 AU AU2356602A patent/AU2356602A/xx active Pending
- 2001-09-27 AT AT01986297T patent/ATE385494T1/de not_active IP Right Cessation
- 2001-09-28 AR ARP010104597A patent/AR032478A1/es unknown
- 2001-10-01 US US09/966,109 patent/US6930130B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2424273A1 (fr) | 2002-04-11 |
JP2004510758A (ja) | 2004-04-08 |
EP1324980A1 (fr) | 2003-07-09 |
MXPA03002343A (es) | 2003-06-30 |
IL155101A0 (en) | 2003-10-31 |
AR032478A1 (es) | 2003-11-12 |
US6930130B2 (en) | 2005-08-16 |
EP1324980B1 (fr) | 2008-02-06 |
ES2298279T3 (es) | 2008-05-16 |
AU2356602A (en) | 2002-04-15 |
DE60132703T2 (de) | 2009-02-05 |
US20020065316A1 (en) | 2002-05-30 |
ATE385494T1 (de) | 2008-02-15 |
WO2002028824A1 (fr) | 2002-04-11 |
EP1193249A1 (fr) | 2002-04-03 |
AU2002223566B2 (en) | 2005-12-22 |
DE60132703D1 (de) | 2008-03-20 |
PT1324980E (pt) | 2008-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20035298D0 (no) | CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler | |
DK1294682T3 (da) | Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
DK1368349T3 (da) | Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler | |
DK1425014T3 (da) | Diarylcycloalkylderivater, fremgangsmåde til deres fremstilling og deres anvendelse som PPAR-aktivatorer | |
NO20006029D0 (no) | Pyrazolinderivater, deres fremstilling og anvendelse som legemidler | |
DK1218341T3 (da) | Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
DK1381605T3 (da) | Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse | |
DK1670458T3 (da) | 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika | |
NO20025357L (no) | Antranylamider og deres anvendelse som legemidler | |
NO20032830L (no) | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer | |
DK1268431T3 (da) | 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer | |
NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
DK1445252T3 (da) | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter | |
NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
DK1370550T3 (da) | Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem | |
DK1322158T3 (da) | Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
DK1406899T3 (da) | Phenylacetamidothiazolderivater, fremgangsmåder til deres fremstilling og deres anvendelse som antitumormidler | |
DK1098891T3 (da) | Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler | |
DK1086077T3 (da) | Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse | |
DK1261603T5 (da) | Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
DK1261625T3 (da) | Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse | |
NO20025209L (no) | Cyklipostiner, deres fremstilling og anvendelse |